CRON stock is leading the cannabis sector higher after an analyst at Bank of America upgraded Cronos Group’s (TSX:CRON) (NASDAQ:CRON) stock.
Big UpgradeOver the past year or so, Cronos Group has emerged as one of the big-ticket players in the medical marijuana industry, and in a new development, the stock started an upsurge on Wednesday following bullish reports from analysts at Bank of America Merrill Lynch. Christopher Grey at Bank of America gave Cronos Group stock a significant boost by giving it a double upgrade as he classified the stock from underperform to buy.
...Read The Full Article On PotStockNews.com
Get the latest marijuana stock news, cannabis on stock news on PotStockNews
All content provided by Pot Stock News is subject to our Terms Of Use and Disclaimer.